AI assistant
Roivant Sciences Ltd. — Director's Dealing 2021
Oct 1, 2021
30587_dirs_2021-10-01_89d0094a-7fdf-4560-800a-1b9560e3e160.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2021-10-01
Reporting Person: Machado Patrick (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $5.19 | 2026-10-19 | Common Shares (170167) | Direct | |
| Stock Option (Right to Buy) | $7.43 | 2027-12-19 | Common Shares (109732) | Direct | |
| Stock Option (Right to Buy) | $11.19 | 2029-01-21 | Common Shares (109732) | Direct | |
| Stock Option (Right to Buy) | $12.68 | 2030-01-19 | Common Shares (109732) | Direct | |
| Stock Option (Right to Buy) | $10.00 | 2031-05-01 | Common Shares (109732) | Direct |
Footnotes
F1: Award of stock options to purchase Common Shares that is fully vested.
F2: Award of stock options to purchase Common Shares with a vesting commencement date of November 30, 2018.
F3: Award of stock options to purchase Common Shares with a vesting commencement date of November 30, 2019.
F4: Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019.
F5: Awards of stock options to purchase Common Shares vest and become exercisable (i) 33% on the first anniversary of the applicable vesting commencement date and (ii) in 24 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.